The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 09, 2014

Filed:

May. 21, 2008
Applicants:

Wenfeng Xu, Seattle, WA (US);

Wayne R. Kindsvogel, Seattle, WA (US);

Zhi Chen, Bellevue, WA (US);

Steven D. Hughes, Kenmore, WA (US);

Yasmin A. Chandrasekher, Saratoga, CA (US);

Stacey R. Dillon, Seattle, WA (US);

Joyce M. Lehner, Seattle, WA (US);

Anthony W. Siadak, Seattle, WA (US);

Pallavar V. Sivakumar, Seattle, WA (US);

Margaret D. Moore, Seattle, WA (US);

Inventors:

Wenfeng Xu, Seattle, WA (US);

Wayne R. Kindsvogel, Seattle, WA (US);

Zhi Chen, Bellevue, WA (US);

Steven D. Hughes, Kenmore, WA (US);

Yasmin A. Chandrasekher, Saratoga, CA (US);

Stacey R. Dillon, Seattle, WA (US);

Joyce M. Lehner, Seattle, WA (US);

Anthony W. Siadak, Seattle, WA (US);

Pallavar V. Sivakumar, Seattle, WA (US);

Margaret D. Moore, Seattle, WA (US);

Assignee:

ZymoGenetics, Inc., Seattle, WA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); A61K 38/17 (2006.01); A61K 47/48 (2006.01); C07K 16/28 (2006.01); C07K 14/715 (2006.01); C07K 14/54 (2006.01); A61K 38/20 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2866 (2013.01); C07K 16/244 (2013.01); A61K 38/1793 (2013.01); C07K 2317/73 (2013.01); A61K 47/48215 (2013.01); A61K 2039/505 (2013.01); C07K 2316/96 (2013.01); C07K 2319/30 (2013.01); C07K 14/7155 (2013.01); C07K 14/54 (2013.01); A61K 38/20 (2013.01);
Abstract

The present invention relates to blocking the activity of IL-20 polypeptide molecules. IL-20 is a cytokine that is involved in inflammatory processes and human disease. IL-20RA/IL-20RB is a common receptor for IL-20. The present invention includes anti-IL-20 antibodies and binding partners, as well as methods for antagonizing IL-20 using such antibodies and binding partners.


Find Patent Forward Citations

Loading…